ArticleNature communications2025

Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling.

Meixia Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.